AVOBENZONE, OCTISALATE, AND OCTOCRYLENE and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

Overview

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is the #7 most commonly reported adverse reaction for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, manufactured by Alchemee, LLC. There are 95 FDA adverse event reports linking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE to INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. This represents approximately 4.4% of all 2,163 adverse event reports for this drug.

Patients taking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE who experience inappropriate schedule of product administration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is moderately reported among AVOBENZONE, OCTISALATE, AND OCTOCRYLENE users, representing a notable but not dominant share of adverse events.

Other Side Effects of AVOBENZONE, OCTISALATE, AND OCTOCRYLENE

In addition to inappropriate schedule of product administration, the following adverse reactions have been reported for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE:

• DRUG INEFFECTIVE — 318 reports
• ACNE — 258 reports
• SKIN BURNING SENSATION — 236 reports
• DRY SKIN — 217 reports
• ERYTHEMA — 178 reports
• SKIN IRRITATION — 148 reports
• SKIN EXFOLIATION — 90 reports
• HYPERSENSITIVITY — 69 reports
• OVERDOSE — 61 reports
• RASH — 55 reports

Other Drugs Associated with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

The following drugs have also been linked to inappropriate schedule of product administration in FDA adverse event reports:

Does AVOBENZONE, OCTISALATE, AND OCTOCRYLENE cause INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION?

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION has been reported as an adverse event in 95 FDA reports for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION with AVOBENZONE, OCTISALATE, AND OCTOCRYLENE?

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION accounts for approximately 4.4% of all adverse event reports for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, making it a notable side effect.

What should I do if I experience INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION while taking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE?

If you experience inappropriate schedule of product administration while taking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages